AILERON THERAPEUTICS, INC.
290 Pleasant Street, Unit 112
Watertown, MA 02472
February 5, 2021
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: |
Aileron Therapeutics, Inc. | |
| Registration Statement on Form S-3 | ||
| File No. 333-252587 | ||
| Request for Acceleration |
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Aileron Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-252587), so that it may become effective at 4:00 p.m. Eastern time on February 9, 2021, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.
| Very truly yours, | ||
| AILERON THERAPEUTICS, INC. | ||
| By: | /s/ Richard J. Wanstall | |
| Name: | Richard J. Wanstall | |
| Title: |
Chief Financial Officer and Treasurer |
| cc: | Stuart M. Falber |
Wilmer Cutler Pickering Hale and Dorr LLP